BS EN ISO 11607-1:2017 – TC:2019 Edition
$217.84
Tracked Changes. Packaging for terminally sterilized medical devices – Requirements for materials, sterile barrier systems and packaging systems
Published By | Publication Date | Number of Pages |
BSI | 2019 | 94 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
1 | compares BS EN ISO 11607-1:2017 |
2 | TRACKED CHANGES Test example 1 |
3 | BS EN ISO 11607-1:2017 to BS EN ISO 11607-1:2009 |
5 | National foreword Compliance with a British Standard cannot confer immunity from legal obligations. Amendments/corrigenda issued since publication |
7 | ForewordEuropean foreword Table — Correlation between normative references and dated EN and ISO standards |
9 | Annex ZA (informative) |
10 | Table ZA.1 — Correspondence between this European Standard and Annex I of Directive 93/42/EEC [OJ L 169] |
12 | Annex ZB (informative) Table ZB.1 — Correspondence between this European Standard and Annex I of Directive 90/385/EEC [OJ L 189] |
14 | Annex ZC (informative) Table ZC.1 — Correspondence between this European Standard and Annex I of Directive 98/79/EC [OJ L 331] |
17 | Foreword |
18 | Introduction |
19 | Packaging for terminally sterilized medical devices — 1 Scope 2 Normative references 3 Terms and definitions 3.1 aseptic presentation introduction and transfer of a sterile product using conditions and procedures that exclude microbial contamination 3.2 bioburden population of viable microorganisms on or in a product or sterile barrier system [SOURCE: ISO/TS 11139:2006] |
20 | 3.3 3.4 3.5 3.6 3.7 3.8 |
21 | 3.9 3.10 3.11 3.12 3.13 3.14 3.15 |
22 | 3.16 3.17 3.18 3.19 3.20 3.21 3.22 |
23 | 3.23 3.24 3.25 3.26 3.27 3.28 3.29 4 General requirements 4.1 General 4.2 Quality systems |
24 | 4.3 Sampling 4.4 Test methods 4.5 Documentation |
25 | 5 Materials and preformed sterile barrier systems 5.1 General requirements |
27 | 5.2 Microbial barrier properties |
28 | 5.3 Compatibility with the sterilization process 5.4 Compatibility with the labelling system |
29 | 5.5 Storage and transport 6 Design and development requirements for packaging systems 6.1 General 6.2 Design |
30 | 6.3 Packaging-system performance testing |
31 | 6.4 Stability testing 7 Information to be provided |
32 | (informative) A.1 Factors influencing the choice of the materials and design of the packaging system Figure A.1 — Interrelationships influencing the choice of appropriate materials for terminally sterilized medical packaging systems A.3 Sterile barrier systems |
35 | Annex B (informative) B.1 General B.2 Packaging materials and preformed sterile barrier systems Table B.1 — Test methods and their status |
47 | Annex C (normative) |
48 | Bibliography |
52 | undefined |
56 | Annex ZA (informative)Relationship between this European Standard and the essential requirements of Directive 93/42/EEC [OJ L 169] aimed to be covered |
58 | Annex ZB (informative)Relationship between this European Standard and the essential requirements of Directive 90/385/EEC [OJ L 189] aimed to be covered |
60 | Annex ZC (informative)Relationship between this European Standard and the essential requirements of Directive 98/79/EC [OJ L 331] aimed to be covered |
63 | undefined |
64 | undefined |
65 | undefined undefined undefined |
69 | undefined undefined undefined |
70 | undefined undefined undefined |
71 | undefined undefined |
73 | undefined |
74 | undefined undefined |
75 | undefined undefined undefined undefined |
76 | undefined |
77 | undefined undefined |
78 | undefined |
81 | undefined |
90 | undefined |
91 | undefined |